Our Small-Cap Drone Name Faces Opportunity After DoD Ramp Up Report
Though shares on under pressure on the news, there’s no long-term concern.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.
The $10K Portfolio’s Fueling Up on Rocket Lab (And Another Stock)
Here’s the plan for Rocket Lab; also, another stock we’re stocking up on today.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Why I’m Not Chasing AMC’s Odyssey
Here’s the latest on our Ocular Therapeutix trading strategy, a planned purchase for today and some additional portfolio news.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.
After a Tough Run for the $10K Portfolio, Time to Get Back in the Win Column
From up 32% to slightly underwater, here’s what recently went awry — and what’s next.
Two Charts, Three Buys and a Fourth Attempt
Planet Labs and Evolv both sit at critical technical areas. Here’s my trading plan.
Adding to 2 Names as We Hope Third Time’s a Charm on a Sale
A third attempt to trim Rackspace is on deck while we make a couple of buys and prepare for a Friday option expiration.